Literature DB >> 27134280

Stabilization of Microcirculation in Patients with Early Systemic Sclerosis with Diffuse Skin Involvement following Rituximab Treatment: An Open-label Study.

Vanessa Smith1, Carmen Pizzorni2, Valeria Riccieri3, Saskia Decuman4, Guy Brusselle5, Michel DE Pauw6, Ellen Deschepper7, Yves Piette8, Barbara Ruaro2, Alberto Sulli2, Els Vandecasteele6, Karin Melsens9, Filip DE Keyser10, Maurizio Cutolo11.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27134280     DOI： 10.3899/jrheum.151018

Source DB:  PubMed          Journal:  J Rheumatol        ISSN： 0315-162X            Impact factor:   4.666


× No keyword cloud information.
  10 in total

Review 1.  Pathogenesis of systemic sclerosis-current concept and emerging treatments.

Authors:  Masutaka Furue; Chikage Mitoma; Hiroki Mitoma; Gaku Tsuji; Takahito Chiba; Takeshi Nakahara; Hiroshi Uchi; Takafumi Kadono
Journal:  Immunol Res       Date:  2017-08       Impact factor: 2.829

Review 2.  Advances in nailfold capillaroscopic analysis in systemic sclerosis.

Authors:  Barbara Ruaro; Alberto Sulli; Vanessa Smith; Carmen Pizzorni; Sabrina Paolino; Elisa Alessandri; Amelia Chiara Trombetta; Maurizio Cutolo
Journal:  J Scleroderma Relat Disord       Date:  2018-03-09

3.  Ultrasound evaluation of endothelial dysfunction in immunoglobulin-resistant children with acute Kawasaki disease.

Authors:  Yizhou Wen; Yanfeng Yang; Yang Wen; Jimei Xi; Tingting Chen; Yaheng Lu; Li Wang; Yiling Liu; Feifei Si
Journal:  Clin Rheumatol       Date:  2022-08-18       Impact factor: 3.650

4.  Changes in Thoracic Cavity Volume After Bilateral Lung Transplantation.

Authors:  Woo Sik Yu; Chul Hwan Park; Hyo Chae Paik; Jin Gu Lee; Seulgi You; Jaeyong Shin; Junho Jung; Seokjin Haam
Journal:  Front Med (Lausanne)       Date:  2022-05-26

Review 5.  Drug Candidates for Autoimmune Diseases.

Authors:  Sabrina Saurin; Myriam Meineck; Gerhard Erkel; Till Opatz; Julia Weinmann-Menke; Andrea Pautz
Journal:  Pharmaceuticals (Basel)       Date:  2022-04-20

6.  Cytokine Profiles as Potential Prognostic and Therapeutic Markers in SARS-CoV-2-Induced ARDS.

Authors:  Francesco Salton; Paola Confalonieri; Giuseppina Campisciano; Rossella Cifaldi; Clara Rizzardi; Daniele Generali; Riccardo Pozzan; Stefano Tavano; Chiara Bozzi; Giulia Lapadula; Gianfranco Umberto Meduri; Marco Confalonieri; Manola Comar; Selene Lerda; Barbara Ruaro
Journal:  J Clin Med       Date:  2022-05-24       Impact factor: 4.964

7.  Safety and Efficacy of B-Cell Depletion with Rituximab for the Treatment of Systemic Sclerosis-associated Pulmonary Arterial Hypertension: A Multicenter, Double-Blind, Randomized, Placebo-controlled Trial.

Authors:  Roham T Zamanian; David Badesch; Lorinda Chung; Robyn T Domsic; Thomas Medsger; Ashley Pinckney; Lynette Keyes-Elstein; Carla D'Aveta; Meagan Spychala; R James White; Paul M Hassoun; Fernando Torres; Andrew J Sweatt; Jerry A Molitor; Dinesh Khanna; Holden Maecker; Beverly Welch; Ellen Goldmuntz; Mark R Nicolls
Journal:  Am J Respir Crit Care Med       Date:  2021-07-15       Impact factor: 30.528

8.  Effects of treatment with rituximab on microcirculation in patients with long-term systemic sclerosis.

Authors:  Verônica Silva Vilela; Bruno Rangel Antunes da Silva; Cláudia Henrique da Costa; Agnaldo José Lopes; Roger Abramino Levy; Rogério Rufino
Journal:  BMC Res Notes       Date:  2018-12-10

9.  Innovations in the Assessment of Primary and Secondary Raynaud's Phenomenon.

Authors:  Barbara Ruaro; Vanessa Smith; Alberto Sulli; Carmen Pizzorni; Samuele Tardito; Massimo Patané; Sabrina Paolino; Maurizio Cutolo
Journal:  Front Pharmacol       Date:  2019-04-16       Impact factor: 5.810

10.  Meta-analysis and trial sequential analysis of shexiang baoxin pill for coronary slow flow.

Authors:  Hongxin Guo; Xingyuan Li; Mingjun Zhu
Journal:  Front Pharmacol       Date:  2022-08-22       Impact factor: 5.988
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.